Safety and Efficacy Study in Non-Responder Hepatitis C Genotype 1 Patients With PHN121.
Phase of Trial: Phase I/II
Latest Information Update: 25 Nov 2013
At a glance
- Drugs PHN 121 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Acronyms ENCHAMP
- 10 Jun 2017 Biomarkers information updated
- 25 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 24 Jan 2010 New trial record